Eli Lilly (United Kingdom)

1.5k papers and 54.4k indexed citations i.

About

In recent decades, authors affiliated with Eli Lilly (United Kingdom) have published 1.5k papers, which have received a total of 54.4k indexed citations. Scholars at this organization have produced 353 papers in Molecular Biology, 287 papers in Psychiatry and Mental health and 239 papers in Cellular and Molecular Neuroscience on the topics of Neuroscience and Neuropharmacology Research (175 papers), Schizophrenia research and treatment (110 papers) and Health Systems, Economic Evaluations, Quality of Life (99 papers). Their work is cited by papers focused on Molecular Biology (14.0k citations), Cellular and Molecular Neuroscience (10.5k citations) and Psychiatry and Mental health (9.1k citations). Authors at Eli Lilly (United Kingdom) collaborate with scholars in United Kingdom, United States and Germany and have published in prestigious journals including Nature, Science and Proceedings of the National Academy of Sciences. Some of Eli Lilly (United Kingdom)'s most productive authors include A­llyn C. Howlett, Michael J. O’Neill, Chris Bushe, Josep María Haro, Diego Novick, Alex M. Thomson, Emanuele Sher, Nicholas Moore, Mark D. Tricklebank and Gary Gilmour.

In The Last Decade

Fields of papers published by authors at Eli Lilly (United Kingdom)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Eli Lilly (United Kingdom) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Eli Lilly (United Kingdom) at the time of their publication.

Countries citing scholars working at Eli Lilly (United Kingdom)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Eli Lilly (United Kingdom). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Eli Lilly (United Kingdom) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Lilly (United Kingdom) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025